AptarGroup, Inc. reported a net sales increase of 6% for the second quarter of 2026, reaching $1.03 billion compared to $966 million in the same period of 2025. The growth was attributed to a 2% positive impact from currency translation and a 3% contribution from acquisitions, while core sales, excluding these factors, rose by 1%. The company's net income attributable to AptarGroup for the quarter was $87.6 million, down from $111.7 million a year earlier, reflecting a diluted earnings per share of $1.36 compared to $1.67 in the prior year.

For the first half of 2026, AptarGroup's net sales increased by 8% to $2.01 billion, up from $1.85 billion in the first half of 2025. Similar to the quarterly results, foreign currency effects and acquisitions each contributed 4% and 3% to the sales growth, respectively. However, core sales growth remained flat at 1% when adjusted for these factors. The decline in net income for the first six months was also notable, with figures at $160.2 million compared to $190.5 million in the previous year.

Operationally, the company faced challenges with rising costs, as the cost of sales as a percentage of net sales increased to 64.4% in the second quarter of 2026 from 62.0% in the same quarter of 2025. This was primarily due to a mix of lower-margin products in the Pharma segment and higher input costs. Selling, general, and administrative expenses also rose, totaling $157.7 million for the second quarter, up from $151.1 million in the prior year. The company recognized $1.4 million in restructuring costs during the quarter, aimed at optimizing its cost structure.

AptarGroup's strategic developments included a share repurchase program, with approximately 403,000 shares repurchased for $50 million in the second quarter. The company also reported a decrease in cash and equivalents to $192.8 million as of June 30, 2026, down from $404.8 million at the end of 2025. The total debt decreased to $1.37 billion, reflecting a reduction in interest-bearing obligations. Looking ahead, AptarGroup expects adjusted earnings per share for the third quarter of 2026 to be in the range of $1.45 to $1.53, with anticipated capital expenditures of approximately $260 million to $280 million for the year.

About APTARGROUP, INC.

AptarGroup, Inc. is a global leader in drug and consumer product dosing, dispensing, and protection technologies, serving markets such as pharmaceuticals, beauty, food, and personal care. With a focus on innovation and sustainability, Aptar offers products like dispensing pumps and aerosol valves. The company targets diverse customers, including major brands, and is expanding through strategic acquisitions and digital health solutions, addressing growing market demands for convenience and eco-friendly packaging.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov